Published in PLoS One on March 22, 2013
The role of intracellular calcium for the development and treatment of neuroblastoma. Cancers (Basel) (2015) 0.80
Cinacalcet inhibits neuroblastoma tumor growth and upregulates cancer-testis antigens. Oncotarget (2016) 0.78
Genetic polymorphisms of CASR and cancer risk: evidence from meta-analysis and HuGE review. Onco Targets Ther (2016) 0.77
Regulation of Differentiation by Calcium-Sensing Receptor in Normal and Tumoral Developing Nervous System. Front Physiol (2016) 0.76
The structure of haplotype blocks in the human genome. Science (2002) 50.88
Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep (1966) 48.83
Neuroblastoma. Lancet (2007) 10.61
Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science (1984) 9.64
Adjusting for multiple testing--when and how? J Clin Epidemiol (2001) 8.85
Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid. Nature (1993) 7.89
The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. J Clin Oncol (2008) 6.66
The International Neuroblastoma Pathology Classification (the Shimada system). Cancer (1999) 6.42
SNPStats: a web tool for the analysis of association studies. Bioinformatics (2006) 5.84
Extracellular calcium sensing and extracellular calcium signaling. Physiol Rev (2001) 4.52
Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell (1993) 4.13
Chromosome 6p22 locus associated with clinically aggressive neuroblastoma. N Engl J Med (2008) 3.80
A new algorithm for haplotype-based association analysis: the Stochastic-EM algorithm. Ann Hum Genet (2004) 3.24
A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor. N Engl J Med (1996) 3.20
Ca2+ signalling checkpoints in cancer: remodelling Ca2+ for cancer cell proliferation and survival. Nat Rev Cancer (2008) 2.85
Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N Engl J Med (1993) 2.52
Common variations in BARD1 influence susceptibility to high-risk neuroblastoma. Nat Genet (2009) 2.47
A986S polymorphism of the calcium-sensing receptor and circulating calcium concentrations. Lancet (1999) 2.47
Autosomal dominant hypocalcaemia caused by a Ca(2+)-sensing receptor gene mutation. Nat Genet (1994) 2.23
Integrative genomics identifies LMO1 as a neuroblastoma oncogene. Nature (2010) 2.21
R990G polymorphism of calcium-sensing receptor does produce a gain-of-function and predispose to primary hypercalciuria. Kidney Int (2007) 2.01
Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma. Nat Genet (2012) 1.74
Cox proportional hazards survival regression in haplotype-based association analysis using the Stochastic-EM algorithm. Eur J Hum Genet (2004) 1.73
Clustered inactivating mutations and benign polymorphisms of the calcium receptor gene in familial benign hypocalciuric hypercalcemia suggest receptor functional domains. J Clin Endocrinol Metab (1996) 1.69
Phenotype restricted genome-wide association study using a gene-centric approach identifies three low-risk neuroblastoma susceptibility Loci. PLoS Genet (2011) 1.57
The role of the calcium-sensing receptor in the development and progression of cancer. Endocr Rev (2009) 1.23
Association of genetic variants in the calcium-sensing receptor with risk of colorectal adenoma. Cancer Epidemiol Biomarkers Prev (2004) 1.16
Blood ionized calcium is associated with clustered polymorphisms in the carboxyl-terminal tail of the calcium-sensing receptor. J Clin Endocrinol Metab (2004) 1.15
Replication of GWAS-identified neuroblastoma risk loci strengthens the role of BARD1 and affirms the cumulative effect of genetic variations on disease susceptibility. Carcinogenesis (2012) 1.14
Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia. Hum Mutat (2000) 1.14
Vitamin D receptor and calcium sensing receptor polymorphisms and the risk of colorectal cancer in European populations. Cancer Epidemiol Biomarkers Prev (2009) 1.13
Identification and dissection of Ca(2+)-binding sites in the extracellular domain of Ca(2+)-sensing receptor. J Biol Chem (2007) 1.13
Structure and function of the human calcium-sensing receptor: insights from natural and engineered mutations and allosteric modulators. J Cell Mol Med (2007) 1.11
Primary hyperparathyroidism and the presence of kidney stones are associated with different haplotypes of the calcium-sensing receptor. J Clin Endocrinol Metab (2006) 1.10
Common variation at BARD1 results in the expression of an oncogenic isoform that influences neuroblastoma susceptibility and oncogenicity. Cancer Res (2012) 1.09
A carboxyl-terminal domain controls the cooperativity for extracellular Ca2+ activation of the human calcium sensing receptor. A study with receptor-green fluorescent protein fusions. J Biol Chem (1998) 1.08
PHOX2B is a novel and specific marker for minimal residual disease testing in neuroblastoma. J Clin Oncol (2008) 1.05
A three-gene expression signature model for risk stratification of patients with neuroblastoma. Clin Cancer Res (2012) 1.02
Prostate cancer in African-American men and polymorphism in the calcium-sensing receptor. Cancer Biol Ther (2010) 0.99
Genetic variation in calcium-sensing receptor and risk for colon cancer. Cancer Epidemiol Biomarkers Prev (2008) 0.99
Genetic variation in the retinoid X receptor and calcium-sensing receptor and risk of colorectal cancer in the Colon Cancer Family Registry. Carcinogenesis (2010) 0.96
Genetic variation at the calcium-sensing receptor (CASR) locus: implications for clinical molecular diagnostics. Clin Biochem (2007) 0.92
Prognostic significance of interleukin-6 single nucleotide polymorphism genotypes in neuroblastoma: rs1800795 (promoter) and rs8192284 (receptor). Clin Cancer Res (2009) 0.90
Polymorphic variation in the GC and CASR genes and associations with vitamin D metabolite concentration and metachronous colorectal neoplasia. Cancer Epidemiol Biomarkers Prev (2011) 0.90
Effects of the lactase 13910 C/T and calcium-sensor receptor A986S G/T gene polymorphisms on the incidence and recurrence of colorectal cancer in Hungarian population. BMC Cancer (2008) 0.89
Amino acids in the cytoplasmic C terminus of the parathyroid Ca2+-sensing receptor mediate efficient cell-surface expression and phospholipase C activation. J Biol Chem (2001) 0.85
Frequency of the calcium-sensing receptor variant A986S in patients with primary hyperparathyroidism. Eur J Endocrinol (2001) 0.83
N-Myc regulates expression of the detoxifying enzyme glutathione transferase GSTP1, a marker of poor outcome in neuroblastoma. Cancer Res (2011) 0.82
The calcium-sensing receptor and parathyroid hormone-related protein are expressed in differentiated, favorable neuroblastic tumors. Cancer (2009) 0.82
The calcium-sensing receptor is silenced by genetic and epigenetic mechanisms in unfavorable neuroblastomas and its reactivation induces ERK1/2-dependent apoptosis. Carcinogenesis (2012) 0.82
Treatment of Ewing sarcoma family of tumors with a modified P6 protocol in children and adolescents. Pediatr Blood Cancer (2011) 0.79
SNPStats: a web tool for the analysis of association studies. Bioinformatics (2006) 5.84
High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene. Cancer Cell (2007) 3.27
Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis. Lancet Oncol (2013) 2.82
Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors. Cancer Discov (2014) 2.64
A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers. J Clin Invest (2012) 2.42
A DNA methylation fingerprint of 1628 human samples. Genome Res (2011) 2.16
Correlation between the protein/creatinine ratio in spot urine and 24-hour urine protein. Nefrologia (2012) 1.97
Cytogenetic prognostication within medulloblastoma subgroups. J Clin Oncol (2014) 1.56
EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma. Cancer Res (2005) 1.37
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma. Acta Neuropathol (2013) 1.35
Genome-wide analysis of gene expression associated with MYCN in human neuroblastoma. Cancer Res (2003) 1.24
Accurate outcome prediction in neuroblastoma across independent data sets using a multigene signature. Clin Cancer Res (2010) 1.15
Sarcopenia in the elderly: diagnosis, physiopathology and treatment. Maturitas (2011) 1.10
Neighborhood density effects in spoken word recognition in Spanish. J Multiling Commun Disord (2004) 1.08
Expression of the neuron-specific protein CHD5 is an independent marker of outcome in neuroblastoma. Mol Cancer (2010) 1.03
Effectiveness of nutritional supplementation on muscle mass in treatment of sarcopenia in old age: a systematic review. J Am Med Dir Assoc (2012) 1.03
A three-gene expression signature model for risk stratification of patients with neuroblastoma. Clin Cancer Res (2012) 1.02
Safety and efficacy of once-daily didanosine, tenofovir and nevirapine as a simplification antiretroviral approach. Antivir Ther (2004) 1.01
Wilms tumor cells with WT1 mutations have characteristic features of mesenchymal stem cells and express molecular markers of paraxial mesoderm. Hum Mol Genet (2010) 0.99
Treatment of relapsed/refractory pediatric sarcomas with gemcitabine and docetaxel. J Pediatr Hematol Oncol (2009) 0.99
DNA hypomethylation affects cancer-related biological functions and genes relevant in neuroblastoma pathogenesis. PLoS One (2012) 0.95
Use of siRNAs and antisense oligonucleotides against survivin RNA to inhibit steps leading to tumor angiogenesis. Oligonucleotides (2004) 0.94
Brain stem tumors in children and adolescents: single institutional experience. Childs Nerv Syst (2013) 0.94
Comprehensive characterization of neuroblastoma cell line subtypes reveals bilineage potential similar to neural crest stem cells. BMC Dev Biol (2009) 0.94
Positional gene expression analysis identifies 12q overexpression and amplification in a subset of neuroblastomas. Cancer Genet Cytogenet (2004) 0.91
Specific gene expression profiles and chromosomal abnormalities are associated with infant disseminated neuroblastoma. BMC Cancer (2009) 0.91
Meat quality of "Galician Mountain" foals breed. Effect of sex, slaughter age and livestock production system. Meat Sci (2011) 0.90
Primary Ewing sarcoma of the tentorium presenting with intracranial hemorrhage in a child. J Neurosurg (2007) 0.90
Long noncoding RNA EWSAT1-mediated gene repression facilitates Ewing sarcoma oncogenesis. J Clin Invest (2014) 0.90
Axenfeld-Rieger ocular anomaly and retinoblastoma caused by constitutional chromosome 13q deletion. Pediatr Blood Cancer (2010) 0.89
Raloxifene as an adjunctive treatment for postmenopausal women with schizophrenia: a double-blind, randomized, placebo-controlled trial. J Clin Psychiatry (2011) 0.88
Activated growth signaling pathway expression in Ewing sarcoma and clinical outcome. Pediatr Blood Cancer (2011) 0.88
LMO4 is an essential cofactor in the Snail2-mediated epithelial-to-mesenchymal transition of neuroblastoma and neural crest cells. J Neurosci (2013) 0.87
Use of angioembolization as an effective technique for the management of pediatric solid tumors. J Pediatr Surg (2009) 0.87
Assessment of plausible bioindicators for plant performance in advanced wastewater treatment systems. Water Res (2010) 0.87
Differential expression of genes mapping to recurrently abnormal chromosomal regions characterize neuroblastic tumours with distinct ploidy status. BMC Med Genomics (2008) 0.86
Analysis of Sp transcription factors in the postmortem brain of chronic schizophrenia: a pilot study of relationship to negative symptoms. J Psychiatr Res (2013) 0.85
Antimicrobial activity of reuterin in combination with nisin against food-borne pathogens. Int J Food Microbiol (2004) 0.85
EphA2-induced angiogenesis in ewing sarcoma cells works through bFGF production and is dependent on caveolin-1. PLoS One (2013) 0.85
Impact of telemedicine assessment on glycemic variability in children with type 1 diabetes mellitus. Diabetes Technol Ther (2013) 0.83
Intra-arterial chemotherapy for retinoblastoma. Challenges of a prospective study. Acta Ophthalmol (2014) 0.82
The calcium-sensing receptor is silenced by genetic and epigenetic mechanisms in unfavorable neuroblastomas and its reactivation induces ERK1/2-dependent apoptosis. Carcinogenesis (2012) 0.82
The calcium-sensing receptor and parathyroid hormone-related protein are expressed in differentiated, favorable neuroblastic tumors. Cancer (2009) 0.82
Refractory nonconvulsive status epilepticus in Creutzfeldt-Jakob disease. Epileptic Disord (2010) 0.81
Removal of the internal mammary sentinel node in breast cancer. Nucl Med Commun (2009) 0.81
Antiangiogenic treatment as a pre-operative management of alveolar soft-part sarcoma. Pediatr Blood Cancer (2011) 0.81
Identification of tumoral glial precursor cells in neuroblastoma. Cancer Lett (2011) 0.80
Genetics of pheochromocytoma and paraganglioma in Spanish pediatric patients. Endocr Relat Cancer (2013) 0.80
Different CTNNB1 mutations as molecular genetic proof for the independent origin of four Wilms tumours in a patient with a novel germ line WT1 mutation. J Med Genet (2007) 0.80
Fibrolamellar hepatocellular carcinoma in an infant and literature review. J Pediatr Hematol Oncol (2008) 0.80
Analysis of the usefulness of biological parameters for the control of activated sludge wastewater treatment plants in an interlaboratory study context. J Environ Monit (2012) 0.80
The scintigraphic index spleen/liver at 30 minutes predicts the success of splenectomy in persistent and chronic primary immune thrombocytopenia. Am J Hematol (2011) 0.79
Treatment of Ewing sarcoma family of tumors with a modified P6 protocol in children and adolescents. Pediatr Blood Cancer (2011) 0.79
The anorexia of ageing: physiopathology, prevalence, associated comorbidity and mortality. A systematic review. Maturitas (2013) 0.79
Comprehensive analysis of tumoral DNA content reveals clonal ploidy heterogeneity as a marker with prognostic significance in locoregional neuroblastoma. Genes Chromosomes Cancer (2007) 0.79
Treatment of disseminated paraganglioma with gemcitabine and docetaxel. Pediatr Blood Cancer (2009) 0.79
Cognitive profiles of three clusters of patients with a first-episode psychosis. Schizophr Res (2013) 0.78
Identification of a putative transcriptome signature common to neuroblastoma and neural crest cells. Dev Neurobiol (2013) 0.77
[Prioritizing patients on waiting list for cataract surgery: preference differences among citizens]. Gac Sanit (2006) 0.77
Computed tomography (CT) predicts accurately the pathologic tumour size in stage I non-small-cell lung cancer (NSCLC). Clin Transl Oncol (2010) 0.77
Prospective study of the impact of the Prosigna assay on adjuvant clinical decision-making in unselected patients with estrogen receptor positive, human epidermal growth factor receptor negative, node negative early-stage breast cancer. Curr Med Res Opin (2015) 0.77